Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

600 public trials 70 recruiting studies

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations
  • University Hospital of Wales Cardiff, Wales, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
View all 17 locations
Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Nantes, France

NCT05943522

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Anyang-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Uijeongbu-si, Gyeonggi-do, South Korea
View all 17 locations
Conditions
Bone Marrow Diseases, CML, Chronic Disease, +14 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Oregon Health & Science University-Knight Cardiovascular Institute Portland, Oregon, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 45 locations